ORIGINAL PAPER
Assessment of hypertransaminasaemia in children with newly diagnosed coeliac disease
 
More details
Hide details
 
Publication date: 2018-06-07
 
 
Pediatr Pol 2018;93(2):139-143
 
KEYWORDS
ABSTRACT
Introduction:
Coeliac disease (CD) is a chronic systemic disorder triggered by ingestion of gluten in generally susceptible individuals and characterised by small intestinal enteropathy. Hypertransaminasaemia is one of the extra-intestinal symptoms of CD, well-defined in adults, but with a limited number of studies from the paediatric population.

Aim of the study:
The aim of our study was to assess the prevalence of abnormal liver enzyme values in newly diagnosed children with CD.

Material and methods:
We retrospectively analysed 168 children with newly diagnosed CD. The diagnosis of CD was detected by serologic testing of coeliac-specific antibodies (anti-transglutaminase antibodies and/or endomysial antibodies) and confirmed by duodenal mucosal biopsies. The blood parameters of alanine aminotransferase (ALT) were collected when available at the time of diagnosis from 137 (81.6%) children who we included in the study. This group was composed of 73 girls and 64 boys, 11-202 months old.

Results:
Prevalence of elevated ALT, defined as > 30 U/l, was 30.7%. We found no significant associations between increased transaminase levels and age, gender, or clinical presentation of CD. When we consider a value of > 40 U/l as a definition of elevated ALT, we found a prevalence 10.9%. Children with hypertransaminasaemia were younger (p = 0.01) and more commonly presented gastrointestinal symptoms (p = 0.03).

Conclusions:
Elevated ALT is a common finding in children with CD – more often among younger groups.
REFERENCES (12)
1.
Husby S, Koletzko S, Korponay-Szabó IR i wsp. The ESPGHAN Working Group on Coeliac Disease Diagnosis: ESPGHAN guidelines for the diagnosis of coeliac disease in children and adolescents. An evidence-based approach. J Pediatr Gastroenterol Nutr 2012; 54: 136-160.
 
2.
Lee GJ, Boyle B, Ediger T i wsp. Hypertransaminasemia in newly diagnosed pediatric patients with celiac disease. J Pediatr Gastroenterol Nutr 2016; 63: 340-343.
 
3.
Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World.
 
4.
J Gastroenterol 2013; 19: 2740-2751.
 
5.
Schwimmer JB, Dunn W, Norman GJ i wsp. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010; 138: 1357-1364.
 
6.
England K, Thorne C, Pembrey L i wsp. Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr 2009; 49: 71-77.
 
7.
Farre C, Esteve M, Curcoy A i wsp. Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostics clue. Am J Gastroenterol 2002; 97: 3176-3181.
 
8.
Äärelä L, Nurminen S, Kivelä L i wsp. Prevalence and associated factors of abnormal liver values in children with celiac disease. Dig Liver Dis 2016; 48: 1023-1029.
 
9.
Arslan N, Büyükgebiz B, Oztürk Y i wsp. The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy finding. Acta Gastroenerol Belg 2005; 68: 424-427.
 
10.
Vajro P, Fontanella A, Mayer M i wsp. Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy. J Pediatr 1993; 122: 416-419.
 
11.
Anania C, De Luca E, De Castro G i wsp. Liver involvement in pediatric celiac disease. World J Gastroenterol 2015; 21: 5813-5822.
 
12.
Vajro P, Paolella G, Pisano P i wsp. Hypertransaminasemia and coeliac disease. Aliment Pharmacol Ther 2012; 35: 202-203.
 
Journals System - logo
Scroll to top